Wegovy in Vials? Novo Nordisk's Strategic Shift to Boost Supply and Challenge Eli Lilly

The Quiet Revolution: Ozempic, the Brain, and the End of 'Food Noise'

Viking Therapeutics Rockets Skyward: Is Their Obesity Drug the Next Market Game-Changer?

GLP-1 Medications: Separating Hype from Health with Expert Insights

Navigating the New Frontier of Weight Loss: Scrutiny Mounts on Telehealth Providers

A Tale of Two Pivots: Hims & Hers Retreats on Weight-Loss Pill, Washington Post Sees Editorial Shift

Pharmalot's Pulse Check: Navigating Pharma's Twists and Turns

Dr. Joel Habener, Visionary Pioneer of Diabetes Treatment and GLP-1 Research, Dies at 88

The Rebound Effect: What Happens When You Stop Taking Popular Weight-Loss Medications?

Novo Nordisk's Bold Gambit: Wegovy Price Slashed by Half for China Debut

The Next Frontier in Weight Management: Exploring the Promise of Oral GLP-1 Pills

The Great Pharma Race: GLP-1s, Billions, and the Battle for What's Next

The Next Frontier: Unpacking 'Ozempic 2.0' and the Future of Weight Management

The Dawn of a New Era in Weight Loss Medicine

A New Era for Weight Loss: The Revolution of GLP-1 Pills and Monthly Shots

A Glimmer of Hope: Repurposing Drugs in the Fight Against Alzheimer's

The Curious Case of Microdosing Obesity Drugs: A New Trend or a Risky Gamble?

Novo Nordisk's Alzheimer's Trial Setback: A Closer Look

LifeMD's Bold New Chapter: A Pure-Play Bet on Virtual Care

The Price Tag Blues: Unpacking Novo Nordisk's Bold Move on Ozempic and Wegovy for Self-Pay Patients

The Unseen Benefit? How Weight-Loss Drugs Might Just Be Fighting Cancer, Too

The Perilous Promise of Quick Fixes: Cullman's Weight Loss Clinic Under Fire

The End of the Needle? How Gene Therapy Could Turn Your Body into a GLP-1 Factory

The Race for a Breakthrough: Pfizer's Bold Bet on Battling Obesity, Outmaneuvering Novo Nordisk

The Billion-Dollar Battle for the Future of Weight Loss: Pfizer Jumps into the Ring

The Great Weight-Loss Gambit: Pfizer Jumps into the Billion-Dollar Battle for Obesity Treatment Supremacy

The Great Weigh-In: Pfizer's Bold Bet in the Billion-Dollar Battle for Obesity Drug Dominance

The High-Stakes Game of Weight Loss: Pfizer's Gambit in the GLP-1 Gold Rush

The Great Prescription Price Shake-Up: Could Trump's Bold Plan Reshape US Healthcare?

The Price of Progress? Unpacking the Billion-Dollar Buzz Around America's New Weight-Loss Fixes

The Hollywood Slimdown: Brooks Nader's Honest Confession and the Price of Perfection

The Weight of Expectation: Hims & Hers Eyes a Major Leap into the GLP-1 Arena

The Weight-Loss Gold Rush: Why All Eyes Are On Viking Therapeutics After a Hefty Biotech Deal

The Billion-Dollar Standoff: Pfizer Unleashes on Novo Nordisk in Metsera Bid Battle

Beyond the Grumble: Unraveling the True Science of Hunger and Satiety

The Production Predicament: How Manufacturing Woes Threaten Novo Nordisk's Blockbuster Drugs

Novo Nordisk Shifts Focus: Why the Cell Therapy Unit is Closing Its Doors

Mounjaro vs. Ozempic: Unpacking the GLP-1 Showdown for Weight Loss Dominance

Novo Nordisk Secures Future in Liver Disease, Acquires Akero Therapeutics in Landmark Deal